As the push for efficiency across the global life sciences industry continues, pharmaceutical, biotech and medtech companies are increasingly turning to contract research organizations (CROs), contract development organizations, medical affairs outsourcing and other service providers for help bringing products to market, manufacturing and distributing products, and improving quality. This trend is creating exciting new opportunities for investors in this burgeoning space.
Find out what’s driving growth in this robust—and rapidly growing—subsector of the life sciences industry, and discover what key considerations should be top of mind when evaluating a potential investment in a pharmaceutical outsourcing company. Watch the video and learn more here.
Investment Opportunities and Tailwinds Driving Growth in Outsourced Pharmaceutical Services
3:55
